Agree DF, the Biotechs are oversold severely even compared to the NASDAQ in this cycle. Some analysts are calling a big bounce very soon. Perfect set up for IHL; on the ground in the US, plenty of exposure PR wise, Ann channeled through Nasdaq, no cheap shares/dilution and potentially great OSA results.
General discussion, page-11472
-
- There are more pages in this discussion • 9,004 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)